February 8, 2025 - 18:09

Brinker International, the parent company of Chili's, has seen a remarkable turnaround in its stock performance, skyrocketing approximately 300% over the past year. This surge marks a significant shift for a company that had experienced relatively stagnant growth in previous years.
In a recent discussion, CEO Kevin Hochman shared insights into the strategies that have fueled this impressive growth. He emphasized the importance of innovation, stating, "We're a $4 billion business. We need to have big ideas." This led to the introduction of their "core four" offerings: fajitas, crispers, margaritas, and burgers, which have resonated well with customers.
However, the company's ambitions extend beyond these staples. Hochman hinted at expanding their menu to include a wider variety of items such as quesadillas, queso, nachos, steaks, and salads, aiming to cater to diverse tastes and preferences. With such strategic initiatives in place, Brinker International appears poised for continued success in the competitive fast-food landscape.
March 16, 2026 - 09:23
Reason RBA set to 'punish' Aussies as businesses warn of 'Covid 2.0' price spiralA stark warning from Australian businesses suggests the nation could be facing a new wave of inflationary pressure, reminiscent of the supply shocks seen during the pandemic. This looming threat is...
March 15, 2026 - 20:51
Did Warren Buffett Know Something Wall Street Doesn't? The Former Berkshire Hathaway CEO Left a $373 Billion Warning for the Stock Market.In his final years at the helm of Berkshire Hathaway, Warren Buffett executed a strategy that stood in stark contrast to the exuberance on Wall Street. While markets celebrated record highs, the...
March 15, 2026 - 09:07
5 Things Every UPS Investor Needs to KnowInvestors in United Parcel Service are navigating a complex environment as the company confronts new pressures on its strategic 2026 financial targets. A significant factor introducing uncertainty...
March 14, 2026 - 21:48
Caribou Biosciences Teases vispa-cel Phase 3 LBCL Plan, Eyes Financing at Leerink ConferenceAt the Leerink Global Healthcare Conference, executives from Caribou Biosciences detailed a strategic roadmap for the coming year, centering on the advancement of their primary investigational...